Microenvironmental considerations in the application of human mesenchymal stem cells in regenerative therapies

Biologics: Targets and Therapy

Volumn 2, Issue 4, 2008, Pages 699-705

  Greco, Steven J ^a   Rameshwar, Pranela ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Bone marrow; Cytokine; Mesenchymal stem cells; Microenvironment

Indexed keywords

EID: 77949359783     PISSN: 11775475     EISSN: 11775491     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Arakaki R, Tamamura H, Premanathan M, et al. 1999. T134, a small-molecule CXCR4 inhibitor, has no cross-drug resistance with AMD3100, a CXCR4 antagonist with a different structure. J Virol, 73:1719-23.
2. Arend WP. 1993. Interleukin-1 receptor antagonist. Adv Immunol, 54:167-227.
3. Bianco P, Riminucci M, Gronthos S, et al. 2001. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells, 19:180-92.
4. Bleul CC, Fuhlbrigge RC, Casasnovas JM, et al. 1996. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med, 184:1101-9.
5. Bresnihan B, Cunnane G. 1998. Interleukin-1 receptor antagonist. Rheum Dis Clin North Amer, 24:615-28.
6. Cashen A, Nervi B, DiPersio J. 2007. AMD3100: CXCR4 antagonist and rapid stem cell-mobilizing agent. Future Oncol, 3:19-27.
7. Chen X, Beutler JA, McCloud TG, et al. 2003. Tannic acid is an inhibitor of CXCL12 (SDF-1alpha)/CXCR4 with antiangiogenic activity. Clin Cancer Res, 9:3115-23.
8. Cheng N, Janumyan YM, Didion L, et al. 2004. Bcl-2 inhibition of T-cell proliferation is related to prolonged T-cell survival. Oncogene, 23:3770-80.
9. Cho KJ, Trzaska KA, Greco SJ, et al. 2005. Neurons derived from human mesenchymal stem cells show synaptic transmission and can be induced to produce the neurotransmitter substance P by interleukin-1 alpha. Stem Cells, 23:383-91.
10. Choi KS, Shin JS, Lee JJ, et al. 2005. In vitro trans-differentiation of rat mesenchymal cells into insulin-producing cells by rat pancreatic extract. Biochem Biophys Res Commun, 330:1299-305.
11. Choy EH, Panayi GS. 2001. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med, 344:907-16.
12. Deans RJ, Moseley AB. 2000. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol, 28:875-84.
13. Dinarello CA. 1994. The interleukin-1 family: 10 years of discovery. FASEB J, 8:1314-25.
14. Eberhardt M, Salmon P, von Mach MA, et al. 2006. Multipotential nestin and Isl-1 positive mesenchymal stem cells isolated from human pancreatic islets. Biochem Biophys Res Commun, 345:1167-76.
15. Gabay C. 2000. IL-1 inhibitors: novel agents in the treatment of rheumatoid arthritis. Expert Opin Invest Drug, 9:113-27.
16. Gong X, He X, Qi L, et al. 2006. Stromal cell derived factor-1 acutely promotes neural progenitor cell proliferation in vitro by a mechanism involving the ERK1/2 and PI-3K signal pathways. Cell Biol Int, 30:466-71.
17. Grassel S, Ahmed N. 2007. Influence of cellular microenvironment and paracrine signals on chondrogenic differentiation. Front Biosci, 12:4946-56.
18. Greco SJ, Corcoran KE, Cho KJ, et al. 2004. Tachykinins in the emerging immune system: relevance to bone marrow homeostasis and maintenance of hematopoietic stem cells. Front Biosci, 9:1782-93.
19. Greco SJ, Liu K, Rameshwar P. 2007. Functional similarities among genes regulated by OCT4 in human mesenchymal and embryonic stem cells. Stem Cells, 25:3143-54.
20. Greco SJ, Rameshwar P. 2007. Enhancing effect of IL-1alpha on neurogenesis from adult human mesenchymal stem cells: implication for inflammatory mediators in regenerative medicine. J Immunol, 179:3342-50.
21. Greco SJ, Zhou C, Ye JH, et al. 2007. An interdisciplinary approach and characterization of neuronal cells transdifferentiated from human mesenchymal stem cells. Stem Cells Dev, 16:811-26.
22. Hannum CH, Wilcox CJ, Arend WP, et al. 1990. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature, 343:336-40.
23. Jeon SJ, Oshima K, Heller S, et al. 2007. Bone marrow mesenchymal stem cells are progenitors in vitro for inner ear hair cells. Mol Cell Neurosci, 34:59-68.
24. Knight DM, Trinh H, Le J, et al. 1993. Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Mol Immunol, 30:1443-53.
25. Lerou PH, Daley GQ. 2005. Therapeutic potential of embryonic stem cells. Blood Rev, 19:321-31.
26. Locksley RM, Killeen N, Lenardo MJ. 2001. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell, 104:487-501.
27. Ong SY, Dai H, Leong KW. 2006. Inducing hepatic differentiation of human mesenchymal stem cells in pellet culture. Biomaterials, 27:4087-97.
28. Ortiz LA, Dutreil M, Fattman C, Pandey AC, Torres G, Go K, Phinney DG. 2007. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci U S A, 104:11002-7.
29. Phinney DG, Prockop DJ. 2007. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells, 25:2896-902.
30. Ponte AL, Marais E, Gallay N, et al. 2007. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells, 25:1737-45.
31. Potian JA, Aviv H, Ponzio NM, et al. 2003. Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol, 171:3426-34.
32. Schantz JT, Chim H, Whiteman M. 2007. Cell guidance in tissue engineering: SDF-1 mediates site-directed homing of mesenchymal stem cells within three-dimensional polycaprolactone scaffolds. Tissue Eng, 13:2615-24.
33. Schmal H, Niemeyer P, Roesslein M, et al. 2007. Comparison of cellular functionality of human mesenchymal stromal cells and PBMC. Cytotherapy, 9:69-79.
34. Trzaska KA, Kuzhikandathil EV, Rameshwar P. 2007. Specification of a dopaminergic phenotype from adult human mesenchymal stem cells. Stem Cells, 25:2797-808.
35. Van Overstraeten-Schlögel N, Beguin Y, Gothot A. 2006. Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells. Eur J Haematol, 76:488-93.
36. Wang Y, Deng Y, Zhou GQ. 2007. SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model. Brain Res. in press.
37. Yan J, Xu L, Welsh AM, et al. 2006. Combined Immunosuppressive Agents or CD4 Antibodies Prolong Survival of Human Neural Stem Cell Grafts and Improve Disease Outcomes in ALS Transgenic Mice. Stem Cells, 24:1976-85.
38. Zhang M, Mal N, Kiedrowski M, et al. 2007. SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J, 21:3197-207.